Incidence of malarial infection and response to antimalarial drugs at Districts Lower Dir and Swat of Khyber Pakhtunkhwa, Pakistan
- PMID: 38515900
- PMCID: PMC10953850
- DOI: 10.1016/j.dialog.2022.100035
Incidence of malarial infection and response to antimalarial drugs at Districts Lower Dir and Swat of Khyber Pakhtunkhwa, Pakistan
Abstract
Malaria is the leading cause of mortality and morbidity all over the world. Several antimalarial drugs are available for the treatment of malaria. The main objective of this study was to investigate the incidence of malarial infection and the use of prescribed antimalarial drugs. A cross-sectional study was carried out to collect quantitative data from selected sites in District Lower Dir and Swat of Malakand Division Khyber Pakhtunkhwa (K.P.), Pakistan. Screening of selected patients was performed using both thick and thin films and was observed with the help of a light microscope. In this study, a total of 2517 blood samples were tested. Overall positive infection was 12% Plasmodium vivax (99.07%) and Plasmodium falciparum (0.92%). Our results evaluate that infection with Plasmodium vivax was higher than Plasmodium falciparum. No other Plasmodium species or mixed infections were observed. The rate of infection was more frequent in males as compared to female patients. The highest percentage was recorded in the summer season (35.07%), while the lowest was documented in the winter (11.7%). Out of 325 patients, 311 (95.7%) were treated with Chloroquine, and the remaining were treated with Artemether. Chloroquine was used as a drug of choice for Plasmodium vivax infection. The present study concludes that Plasmodium vivax and Plasmodium falciparum are the two common agents for malaria in Malakand Division. However, Plasmodium vivax was dominant over Plasmodium falciparum. The infection rate was high in males from District Lower Dir during the summer season.
Keywords: Antimalarial drugs; Chloroquine; Incidence; Malaria; Plasmodium falciparum; Plasmodium vivax.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Simple Molecular Methods for Early Detection of Chloroquine Drug Resistance in Plasmodium vivax and Plasmodium falciparum.J Clin Diagn Res. 2016 Jul;10(7):DC19-23. doi: 10.7860/JCDR/2016/18596.8154. Epub 2016 Jul 1. J Clin Diagn Res. 2016. PMID: 27630842 Free PMC article.
-
Baseline survey for malaria prevalence in Khyber Pakhtunkhwa Province, Pakistan.East Mediterr Health J. 2020 Apr 16;26(4):453-460. doi: 10.26719/emhj.19.015. East Mediterr Health J. 2020. PMID: 32338364
-
UK malaria treatment guidelines.J Infect. 2007 Feb;54(2):111-21. doi: 10.1016/j.jinf.2006.12.003. Epub 2007 Jan 9. J Infect. 2007. PMID: 17215045
-
The high risk of malarial recurrence in patients with Plasmodium-mixed infection after treatment with antimalarial drugs: a systematic review and meta-analysis.Parasit Vectors. 2021 May 25;14(1):280. doi: 10.1186/s13071-021-04792-5. Parasit Vectors. 2021. PMID: 34034802 Free PMC article.
-
Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.Acta Trop. 2004 Feb;89(3):351-6. doi: 10.1016/j.actatropica.2003.10.012. Acta Trop. 2004. PMID: 14744561 Review.
References
-
- Organization, W.H . Vol. 2018. World Health Organization; Geneva, Switzerland: 2018. World malaria report 2018.
-
- Organization W.H. 2019. World malaria report 2019.
-
- Mohammad J., Rahim F., Ali S. Malaria; causal parasite and clinical features in pediatric patients. J Med Sci. 2014;22(1):39–42.
-
- Kakar Q., Khan M.A., Bile K.M. Malaria control in Pakistan: new tools at hand but challenging epidemiological realities. East Mediterr Health J. 2010;16(Supp):54–60. (2010) - PubMed
-
- Collins W.E. Plasmodium knowlesi: a malaria parasite of monkeys and humans. Annu Rev Entomol. 2012;57:107–121. - PubMed
LinkOut - more resources
Full Text Sources